Inolife Sciences is an emerging specialty medical device company focused on developing and commercializing novel drug delivery technologies. Inolife commercializes FDA-cleared needle-free injection systems. The company was founded to take advantage of novel techniques of liquid jet and ballistics-based epidermal drug injection that improve patients’ quality of life by making medicines easier to administer, work better, and remove the anxiety and inconvenience associated with hypodermic needle injections.
The “Inojex System” provides for needle-free delivery of drugs and biologics as a liquid jet into the subcutaneous tissue.
The patented “Nanojex System” painlessly delivers medicines through the skin by using a gas jet to accelerate powdered nanoparticles of drug or protein to supersonic speed with a single-use, disposable, handheld device.
Inolife Sciences is developing products based on proprietary delivery technologies in several important fields, including diabetes, pain management, erectile dysfunction, chronic anemia, autoimmune rheumatoid arthritis, growth & fertility hormones, psoriasis, and for DNA and conventional/pediatric vaccines.
Our R&D focus is specifically on the market for injectable drugs, biosimilar biologic molecules, and vaccines. Our Needle-Free technology is ideal for a broad spectrum of uses, such as Diabetes, Dental Anesthesia, Vaccination, Autoimmune Disease, Erectile Dysfunction, Cancer, Growth Hormone, Cosmetics, and Veterinary.
Inojex delivers a fine stream of medication subcutaneously (under the skin) without using a needle. Injections made with Inojex are virtually pain-free and do not lead to tissue damage on long term use. The Inojex injector is a reusable device, it utilizes disposable ampoules and other accessories.